Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIMS: Mirasol System for Malaria Prevention
NCT02118428Completed
- Sponsor
- Terumo
- Start
- Mar 2014
- Primary completion
- Dec 2014
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Terumo. Primary endpoint: Percentage of Participants With Incidence of Transfusion-transmitted Malaria at 28 days. Started Mar 2014; status: completed.
Beyond the preview
Go deeper on NCT02118428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02118428.